1. Home
  2. ALDX vs VOXR Comparison

ALDX vs VOXR Comparison

Compare ALDX & VOXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • VOXR
  • Stock Information
  • Founded
  • ALDX 2004
  • VOXR 2014
  • Country
  • ALDX United States
  • VOXR United States
  • Employees
  • ALDX N/A
  • VOXR N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • VOXR Precious Metals
  • Sector
  • ALDX Health Care
  • VOXR Basic Materials
  • Exchange
  • ALDX Nasdaq
  • VOXR Nasdaq
  • Market Cap
  • ALDX 160.8M
  • VOXR 168.0M
  • IPO Year
  • ALDX 2014
  • VOXR N/A
  • Fundamental
  • Price
  • ALDX $4.76
  • VOXR $3.11
  • Analyst Decision
  • ALDX Strong Buy
  • VOXR
  • Analyst Count
  • ALDX 2
  • VOXR 0
  • Target Price
  • ALDX $9.50
  • VOXR N/A
  • AVG Volume (30 Days)
  • ALDX 1.2M
  • VOXR 810.3K
  • Earning Date
  • ALDX 07-31-2025
  • VOXR 08-06-2025
  • Dividend Yield
  • ALDX N/A
  • VOXR 1.55%
  • EPS Growth
  • ALDX N/A
  • VOXR N/A
  • EPS
  • ALDX N/A
  • VOXR N/A
  • Revenue
  • ALDX N/A
  • VOXR $10,845,445.00
  • Revenue This Year
  • ALDX N/A
  • VOXR $16.51
  • Revenue Next Year
  • ALDX N/A
  • VOXR $4.60
  • P/E Ratio
  • ALDX N/A
  • VOXR N/A
  • Revenue Growth
  • ALDX N/A
  • VOXR N/A
  • 52 Week Low
  • ALDX $1.14
  • VOXR $2.21
  • 52 Week High
  • ALDX $7.20
  • VOXR $3.79
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 78.74
  • VOXR 38.82
  • Support Level
  • ALDX $4.12
  • VOXR $3.13
  • Resistance Level
  • ALDX $4.60
  • VOXR $3.42
  • Average True Range (ATR)
  • ALDX 0.29
  • VOXR 0.15
  • MACD
  • ALDX 0.08
  • VOXR -0.03
  • Stochastic Oscillator
  • ALDX 90.91
  • VOXR 8.06

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About VOXR Vox Royalty Corp.

Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.

Share on Social Networks: